PL445283A1 - Sposób nieinwazyjnej analizy płodowego DNA oraz frakcji płodu z wykorzystaniem reakcji multipleks digital PCR - Google Patents
Sposób nieinwazyjnej analizy płodowego DNA oraz frakcji płodu z wykorzystaniem reakcji multipleks digital PCRInfo
- Publication number
- PL445283A1 PL445283A1 PL445283A PL44528323A PL445283A1 PL 445283 A1 PL445283 A1 PL 445283A1 PL 445283 A PL445283 A PL 445283A PL 44528323 A PL44528323 A PL 44528323A PL 445283 A1 PL445283 A1 PL 445283A1
- Authority
- PL
- Poland
- Prior art keywords
- fetal
- digital pcr
- multiplex digital
- invasive analysis
- fractions
- Prior art date
Links
- 230000001605 fetal effect Effects 0.000 title abstract 5
- 238000007847 digital PCR Methods 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 238000004458 analytical method Methods 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 102100028552 40S ribosomal protein S4, Y isoform 2 Human genes 0.000 abstract 1
- 101000696127 Homo sapiens 40S ribosomal protein S4, Y isoform 2 Proteins 0.000 abstract 1
- 101000808590 Homo sapiens Probable ubiquitin carboxyl-terminal hydrolase FAF-Y Proteins 0.000 abstract 1
- 101000780650 Homo sapiens Protein argonaute-1 Proteins 0.000 abstract 1
- 101000826130 Homo sapiens Sex-determining region Y protein Proteins 0.000 abstract 1
- 102100038600 Probable ubiquitin carboxyl-terminal hydrolase FAF-Y Human genes 0.000 abstract 1
- 102100034183 Protein argonaute-1 Human genes 0.000 abstract 1
- 102100022978 Sex-determining region Y protein Human genes 0.000 abstract 1
- 210000002593 Y chromosome Anatomy 0.000 abstract 1
- 239000012620 biological material Substances 0.000 abstract 1
- 230000020509 sex determination Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6879—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for sex determination
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2537/00—Reactions characterised by the reaction format or use of a specific feature
- C12Q2537/10—Reactions characterised by the reaction format or use of a specific feature the purpose or use of
- C12Q2537/143—Multiplexing, i.e. use of multiple primers or probes in a single reaction, usually for simultaneously analyse of multiple analysis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2537/00—Reactions characterised by the reaction format or use of a specific feature
- C12Q2537/10—Reactions characterised by the reaction format or use of a specific feature the purpose or use of
- C12Q2537/16—Assays for determining copy number or wherein the copy number is of special importance
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2537/00—Reactions characterised by the reaction format or use of a specific feature
- C12Q2537/10—Reactions characterised by the reaction format or use of a specific feature the purpose or use of
- C12Q2537/165—Mathematical modelling, e.g. logarithm, ratio
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Sposób analizy wolnokrążącego płodowego cffDNA w celu determinacji płci oraz oceny frakcji płodu charakteryzujący się tym, że pobiera się materiał biologiczny od ciężarnej pacjentki, izoluje się cffDNA, ocenia się płodowe DNA, przeprowadza się reakcję multipleks digital PCR w celu amplifikacji genów na chromosomie Y obejmujących RPS4Y2, SRY, USP9Y oraz genów referencyjnych RPPH1, TERT, EIF2C1 i analizuje się dane.
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL445283A PL445283A1 (pl) | 2023-06-20 | 2023-06-20 | Sposób nieinwazyjnej analizy płodowego DNA oraz frakcji płodu z wykorzystaniem reakcji multipleks digital PCR |
| PCT/PL2024/050042 WO2024263045A1 (en) | 2023-06-20 | 2024-06-20 | Method of non-invasive fetal dna and fetal fraction analysis using multiplex digital pcr reaction |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL445283A PL445283A1 (pl) | 2023-06-20 | 2023-06-20 | Sposób nieinwazyjnej analizy płodowego DNA oraz frakcji płodu z wykorzystaniem reakcji multipleks digital PCR |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL445283A1 true PL445283A1 (pl) | 2024-12-23 |
Family
ID=93936122
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL445283A PL445283A1 (pl) | 2023-06-20 | 2023-06-20 | Sposób nieinwazyjnej analizy płodowego DNA oraz frakcji płodu z wykorzystaniem reakcji multipleks digital PCR |
Country Status (2)
| Country | Link |
|---|---|
| PL (1) | PL445283A1 (pl) |
| WO (1) | WO2024263045A1 (pl) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013055817A1 (en) * | 2011-10-11 | 2013-04-18 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
| WO2018178700A1 (en) * | 2017-03-31 | 2018-10-04 | Premaitha Limited | Method of detecting a fetal chromosomal abnormality |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2909479A1 (en) * | 2013-05-09 | 2014-11-13 | F. Hoffmann-La Roche Ag | Method of determining the fraction of fetal dna in maternal blood using hla markers |
-
2023
- 2023-06-20 PL PL445283A patent/PL445283A1/pl unknown
-
2024
- 2024-06-20 WO PCT/PL2024/050042 patent/WO2024263045A1/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013055817A1 (en) * | 2011-10-11 | 2013-04-18 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
| WO2018178700A1 (en) * | 2017-03-31 | 2018-10-04 | Premaitha Limited | Method of detecting a fetal chromosomal abnormality |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2024263045A1 (en) | 2024-12-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Delacher et al. | Single-cell chromatin accessibility landscape identifies tissue repair program in human regulatory T cells | |
| Heijmans et al. | Commentary: The seven plagues of epigenetic epidemiology | |
| Miyazaki et al. | The E-Id protein axis specifies adaptive lymphoid cell identity and suppresses thymic innate lymphoid cell development | |
| Miyazaki et al. | The opposing roles of the transcription factor E2A and its antagonist Id3 that orchestrate and enforce the naive fate of T cells | |
| Gorkin et al. | Integration of ChIP-seq and machine learning reveals enhancers and a predictive regulatory sequence vocabulary in melanocytes | |
| Ahci et al. | A new tool for rapid and reliable diagnosis of HLA loss relapses after HSCT | |
| Gulley et al. | Genetic tests to evaluate prognosis and predict therapeutic response in acute myeloid leukemia | |
| JP2012511917A5 (pl) | ||
| Ishida et al. | Maternal peripheral blood natural killer cells incorporate placenta-associated microRNAs during pregnancy | |
| CA3210811A1 (en) | Antigen reactive t-cell receptors | |
| EP3353318B1 (en) | Lrp5 as epigenetic marker for the identification of immune cells, in particular b-cells | |
| MX2022009119A (es) | Un reloj epigenetico para galliformes. | |
| Yabuki et al. | Triplet repeat polymorphism in the MICA gene in HLA-B27 positive and negative Caucasian patients with ankylosing spondylitis | |
| de Barrios et al. | HDAC7 is a major contributor in the pathogenesis of infant t (4; 11) proB acute lymphoblastic leukemia | |
| Moron-Lopez et al. | The genome-wide methylation profile of CD4+ T cells from individuals with human immunodeficiency virus (HIV) identifies distinct patterns associated with disease progression | |
| Tomusiak et al. | Development of a novel epigenetic clock resistant to changes in immune cell composition | |
| PL445283A1 (pl) | Sposób nieinwazyjnej analizy płodowego DNA oraz frakcji płodu z wykorzystaniem reakcji multipleks digital PCR | |
| EP3353321B1 (en) | Mvd as epigenetic marker for the identification of cd56+ nk cells | |
| Yuan et al. | Reactivation of HIV-1 proviruses in immune-compromised mice engrafted with human VOA-negative CD4+ T cells | |
| Bina et al. | The expression of lnc-IL-7R long non-coding RNA dramatically correlated with soluble and membrane-bound isoforms of IL-7Ra gene in multiple sclerosis patients | |
| de Coaña et al. | Quantifying Aotus monkey cytokines by real-time quantitative RT-PCR | |
| Vecellio et al. | Advanced genomics and clinical phenotypes in psoriatic arthritis | |
| EP3669003B1 (en) | Pdcd1 as epigenetic marker for the identification of immune cells, in particular pd1+ cells | |
| van Hamburg et al. | Gene expression profiling in mice with enforced Gata3 expression reveals putative targets of Gata3 in double positive thymocytes | |
| Pessia | Deciphering the immune microenvironment in pediatric Acute Myeloid Leukaemia (AML) using single-cell multi-omics |